Skip to main content
. 2013 Apr 15;447(1-2):124–131. doi: 10.1016/j.ijpharm.2013.02.034

Fig. 5.

Fig. 5

The de-agglomeration profiles of the inhaled powders beclometasone dipropionate (BDP), budesonide (Bud), fluticasone propionate (FP), lactohale 300 (LH300), salbutamol base (SB), salmeterol xinafoate (SX) and tofimilast (Tof) measured by Sympatec HELOS/RODOS dry dispersion laser diffraction (mean ± SD, n = 3).